Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alaunos Therapeutics ( (TCRT) ) just unveiled an update.
On April 9, 2026, Alaunos Therapeutics disclosed it had received notice from Nasdaq that it was no longer in compliance with the exchange’s listing rule requiring at least $2.5 million in stockholders’ equity, after reporting equity of $2.153 million for the year ended December 31, 2025. The company also failed to meet alternative listing criteria related to market value and net income, raising the risk of potential delisting if it cannot remedy the shortfall.
Alaunos has until May 26, 2026, to submit a plan to regain compliance, with Nasdaq able to grant up to 180 days from the notice date to restore its stockholders’ equity to the required level. Trading in the company’s shares is expected to continue during this process, but there is no assurance its plan will be accepted, and any failure to comply could ultimately lead to a hearing before a Nasdaq panel and heighten uncertainty for shareholders.
Spark’s Take on TCRT Stock
According to Spark, TipRanks’ AI Analyst, TCRT is a Neutral.
Alaunos Therapeutics’ overall score is primarily impacted by its weak financial performance with ongoing losses and negative cash flows. While the technical analysis shows some positive momentum, the negative P/E ratio and lack of dividends underscore valuation challenges. The absence of earnings call and corporate events information further limits the stock’s appeal.
To see Spark’s full report on TCRT stock, click here.
More about Alaunos Therapeutics
Alaunos Therapeutics, Inc. operates in the biopharmaceutical sector and is listed on the Nasdaq Capital Market. The company focuses on developing therapeutics, relying on equity and capital markets access to support its operations and maintain compliance with public listing standards.
Average Trading Volume: 16,015
Technical Sentiment Signal: Sell
Current Market Cap: $7.04M
For detailed information about TCRT stock, go to TipRanks’ Stock Analysis page.